Media Release - 12 April 2010 Review of new medicines for people recovering from hip and knee replacements

Resize font:

Home > News > Past News > Media Release - 12 April 2010 Review of new medicines for people recovering from hip and knee replacements

Media Release - 12 April 2010 Review of new medicines for people recovering from hip and knee replacements

More than 70,000 Australians undergo hip and knee replacements every year, and need anticoagulant medicines for up to a month after surgery to prevent serious blood clots from forming.

To help people understand these medicines and how to use them safely, the latest edition of NPS Medicine Update provides independent reviews of the oral medicines dabigatran (Pradaxa) and rivaroxaban (Xarelto), listed on the PBS for preventing blood clots after hip or knee replacement surgery.

click here for the full media release MEDIA RELEASE NPS 12 April 2010

Reviewed and updated June 2012

SUPPORT US

We are a patient and community driven organisation and extend an invitation to all Australians to

Make a donation
Fundraise
Become a member
Become a sponsor
Become a volunteer
Make a bequest
Invest in arthritis research

MULTICULTURAL INFORMATION

Select from the below to view key information sheets in various languages:

( Arabic )
( Chinese )
( Greek )
( Italian )
( Vietnamese )

MICHAEL SLATER'S GREATEST TEST

Ankylosing spondylitis (AS) is a disease which causes inflammation and pain in the spine and other joints. It affects up to 2% of Australians and is three times more common in men than women.

Michael Slater is one of our greatest cricketing legends yet, behind the scenes, his career was all but the perfect over ...

Click here to find out more about AS and read about Michael Slater's greatest test.

NEWSFEED

Proud partner of:

This site complies with the HONcode standard for trustworthy health information:
verify here.

Arthritis Australia

More than 70,000 Australians undergo hip and knee replacements every year, and need anticoagulant medicines for up to a month after surgery to prevent serious blood clots from forming.

To help people understand these medicines and how to use them safely, the latest edition of NPS Medicine Update provides independent reviews of the oral medicines dabigatran (Pradaxa) and rivaroxaban (Xarelto), listed on the PBS for preventing blood clots after hip or knee replacement surgery.

click here for the full media release MEDIA RELEASE NPS 12 April 2010